Agriculture

  • Request for Nominations of Members for the National Agricultural Research, Extension, Education, and Economics Advisory Board, Specialty Crop Committee, Citrus Disease Subcommittee, and National Genetic Resources Advisory Council

    AGENCY: National Agricultural Research, Extension, Education, and Economics Advisory Board, Office of the Secretary, USDA.

    ACTION: Solicitation for membership.


    SUMMARY: In accordance with the Federal Advisory Committee Act, the U.S. Department of Agriculture (USDA) announces the opening of the solicitation for nominations to fill vacancies on the National Agricultural Research, Extension, Education, and Economics (NAREEE) Advisory Board and its subcommittees. There is one vacancy on the NAREEE Advisory Board; nine vacancies on the National Genetic Resources Advisory Council; three vacancies on the Specialty Crop Committee; and eight vacancies on the Citrus Disease Subcommittee.

    DATES: All nomination materials should be submitted in a single, complete package and received or postmarked by April 26, 2019.

    ADDRESSES: The nominee's name, resume or CV, completed and signed Form AD-755, and any letters of support must be submitted via one of the following methods: (1) Email (preferred) to nareeeab@ars.usda.gov; (2) By fax to 202-720-6199; or (3) By mail delivery service to: REE Advisory Board Office, U.S. Department of Agriculture, Jamie L. Whitten Building, Room 332-A, 1400 Independence Avenue SW, Washington, DC 20250-2255.

    FOR FURTHER INFORMATION CONTACT: Michele Esch, Director, National Agricultural Research, Extension, Education, and Economics Advisory Board, 1400 Independence Avenue SW, Room 332A, The Whitten Building, Washington, DC 20250-2255; telephone: 202-720-3684; fax: 202-720-6199; email: nareeeab@ars.usda.gov. Committee website: www.nareeeab.ree.usda.gov.

    https://www.govinfo.gov/content/pkg/FR-2019-03-28/html/2019-05938.htm

  • Health and Human Services

  • Advisory Council on Alzheimer's Research, Care, and Services; Meeting

    AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

    ACTION: Notice of meeting.


    SUMMARY: This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer's Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people with the disease and their caregivers. The April 29, 2019 meeting of the Advisory Council will focus on person-centered planning for older adults including information about implementation of care plans for people living with cognitive symptoms. There will also be discussion about the use of antipsychotic medication for people with dementia and other conditions living in community settings.

    DATES: The meeting will be held on April 29, 2019 from 9 a.m. to 4:30 p.m. EST.

    ADDRESSES: The meeting will be held in Room 800 in the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201.

    Comments: Time is allocated on the agenda to hear public comments. The time for oral comments will be limited to two (2) minutes per individual. In lieu of oral comments, formal written comments may be submitted for the record to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to napa@hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations.

    FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, helen.lamont@hhs.gov. Note: Seating may be limited. Those wishing to attend the meeting must send an email to napa@hhs.gov and put "April 29 Meeting Attendance" in the subject line by Friday, April 19 so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email.

    https://www.govinfo.gov/content/pkg/FR-2019-03-29/html/2019-06135.htm

  • Antimicrobial Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notice; establishment of a public docket; request for comments.


    SUMMARY: The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Antimicrobial Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.

    DATES: The meeting will be held on April 26, 2019, from 8:30 a.m. to 1 p.m.

    ADDRESSES: Tommy Douglas Conference Center, the Ballroom, 10000 New Hampshire Ave., Silver Spring, MD 20903. The conference center's telephone number is 240-645-4000.

    Answers to commonly asked questions about FDA Advisory Committee meetings may be accessed at: https://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm408555.htm. Information about the Tommy Douglas Conference Center can be accessed at: https://www.tommydouglascenter.com/.

    FDA is establishing a docket for public comment on this meeting. The docket number is FDA-2019-N-0795. The docket will close on April 25, 2019. Submit either electronic or written comments on this public meeting by April 25, 2019. Please note that late, untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of April 25, 2019. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date.

    Comments received on or before April 11, 2019, will be provided to the committee. Comments received after that date will be taken into consideration by FDA.

    You may submit comments as follows:

    Electronic Submissions

    Submit electronic comments in the following way:

    Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else's Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov.

    If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see "Written/Paper Submissions" and "Instructions").

    Written/Paper Submissions

    Submit written/paper submissions as follows:

    Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in "Instructions."

    Instructions: All submissions received must include the Docket No. FDA-2019-N-0795 for "Antimicrobial Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments." Received comments, those filed in a timely manner (see ADDRESSES), will be placed in the docket and, except for those submitted as "Confidential Submissions," publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday.

    Confidential Submissions--To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states "THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION." FDA will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify the information as "confidential" Any information marked as "confidential" will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA's posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.

    Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the "Search" box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

    FOR FURTHER INFORMATION CONTACT: Lauren Tesh, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, Fax: 301-847-8533, AMDAC@fda.hhs.gov; or the FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check FDA's website at https://www.fda.gov/AdvisoryCommittees/default.htm and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.

    https://www.govinfo.gov/content/pkg/FR-2019-03-25/html/2019-05652.htm

  • Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)

    AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).

    ACTION: Notice of meeting.


    SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID). This meeting is open to the public, limited only by the space available; the meeting room will accommodate up to 100 people. The public is also welcome to listen to the meeting by telephone, limited only by the number of ports available (100); the toll-free dial-in number is 1-877-951-7311, with a passcode of 2286986.

    DATES: The meeting will be held on May 7, 2019, 12:30 p.m. to 5:30 p.m., EDT, and May 8, 2019, 8:30 a.m. to 3:30 p.m., EDT.

    ADDRESSES: CDC, Global Communications Center, 1600 Clifton Road NE, Building 19, Auditorium B3, Atlanta, Georgia 30329-4027; also 1-877- 951-7311, with a passcode of 2286986.

    FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia 30329-4027, Telephone (404) 639-4840; SWiley@cdc.gov.

    https://www.govinfo.gov/content/pkg/FR-2019-03-29/html/2019-06086.htm

  • National Science Foundation

  • Advisory Committee for Education and Human Resources; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92- 463, as amended), the National Science Foundation announces the following meeting:

    Name and Committee Code: Advisory Committee for Education and Human Resources (#1119).

    Date and Time: April 25, 2019; 8:00 a.m.-5:00 p.m.

    Place: National Science Foundation, 2415 Eisenhower Avenue, Room E2030, Alexandria, VA 22314.

    To attend the meeting in person, all visitors must contact the Directorate for Education and Human Resources at least 48 hours prior to the meeting to arrange for a visitor's badge. All visitors must access NSF via the Visitor Center entry adjacent to the south building entrance on Eisenhower Avenue on the day of the meeting to receive a visitor's badge. It is suggested that visitors allow time to pass through security screening.

    Type of Meeting: Open.

    Contact Person: Keaven M. Stevenson, National Science Foundation, 2415 Eisenhower Avenue, Room C11001, Alexandria, VA 22314; (703) 292-8600/kstevens@nsf.gov.

    Summary of Minutes: Minutes and meeting materials will be available on the EHR Advisory Committee website at http://www.nsf.gov/ehr/advisory.jsp or can be obtained from Dr. Nafeesa Owens, National Science Foundation, 2415 Eisenhower Ave., Room C11045, Alexandria, VA 22314; (703) 292-8600/nowens@nsf.gov.

    Purpose of Meeting: To provide advice with respect to the Foundation's science, technology, engineering, and mathematics (STEM) education and human resources programming.

    Agenda

    Thursday, April 25, 2019, 8:30 a.m.-5:00 p.m.

    Morning Sessions

    Remarks from the EHR Advisory Committee Chair and EHR Assistant Director

    Update on Federal STEM Education 5-Year Strategic Plan

    Updates on NSF BIG IDEAS and from EHR AC Subcommittees Afternoon Sessions

    Graduate Education AC Subcommittee Report

    Committee Business: Committee of Visitors

    EHR Evaluation

    Discussion with NSF Director, France Cordova and Chief Operating Officer, F. Fleming Crim

    Final agenda can be located at the EHR AC: https://www.nsf.gov/ehr/advisory.jsp.

    https://www.govinfo.gov/content/pkg/FR-2019-03-29/html/2019-06023.htm

  • Advisory Committee for Polar Programs; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92- 463, as amended), the National Science Foundation (NSF) announces the following meeting:

    Name and Committee Code: Advisory Committee for Polar Programs (1130).

    Date and Time: May 1, 2019; 9:00 a.m.-5:00 p.m., May 2, 2019; 9:00 a.m.-3:00 p.m.

    Place: National Science Foundation, 2415 Eisenhower Avenue, Alexandria, Virginia 22314, Room 2010.

    Type of Meeting: Open.

    Contact Person: Andrew Backe, National Science Foundation, Room W 7237, 2415 Eisenhower Avenue, Alexandria, Virginia 22314; Phone 703- 292-2454.

    Minutes: May be obtained from the contact person listed above.

    Purpose of Meeting: To provide advice and recommendations to the National Science Foundation concerning support for polar research, education, infrastructure and logistics, and related activities.

    Agenda

    May 1, 2019; 9:00 a.m.-5:00 p.m.

    Opening Remarks and Introductions

    Antarctic Treaty

    Polar Cyberinfrastructure

    Arctic Portfolio Review Subcommittee Report

    Polar Research Vessel Requirements Subcommittee Report

    Safety Discussion

    IARPC Principles Document

    USAP Communications & Community Outreach Charter

    Astrophysics Decadal Process Update

    May 2, 2019; 9:00 a.m.-3:00 p.m.

    Polar Advisory Overview Document

    Joint Session with AC-MPS

    Meeting with the NSF COO

    Wrap-up and Actions

    https://www.govinfo.gov/content/pkg/FR-2019-03-29/html/2019-06076.htm

back to Federal Register Resource

Bookmark and Share